This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Osaka University. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations in Pain Treatment by Shoichi Shimada
Introduction
Shoichi Shimada is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain. His innovative approach focuses on utilizing serotonin-3 receptor agonists to address chronic and acute pain effectively.
Latest Patents
Shimada holds a patent for a groundbreaking invention titled "Treatment of pain with serotonin-3 receptor agonist." This patent describes a pharmaceutical composition that includes a serotonin-3 receptor agonist, which is effective in preventing or treating chronic pain. The composition can also be used for acute pain management. The invention outlines a method for screening compounds that exhibit serotonin-3 receptor agonist activity, further enhancing the potential for pain treatment.
Career Highlights
Shoichi Shimada is affiliated with Osaka University, where he conducts research and develops innovative solutions in pain management. His work has garnered attention for its potential to improve the quality of life for individuals suffering from chronic pain conditions.
Collaborations
Shimada collaborates with esteemed colleagues, including Yukiko Yamamoto and Makoto Kondo. Their combined expertise contributes to advancing research in the pharmaceutical field.
Conclusion
Shoichi Shimada's contributions to pain treatment through his innovative patent highlight the importance of research in developing effective therapies. His work continues to pave the way for advancements in pain management, benefiting countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
